The global central nervous system drugs market is expected to reach around $82 billion in 2020. Going forward, the growth of this market can be attributed to steps taken by the US FDA (Food and Drug Administration) and EMA (European Medicines Agency) to offer allotment of special regulatory designations for Central Nervous System disorders which will help in the faster entry of drugs into the market for treatment of serious nervous system related conditions.
Central Nervous System Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs sector.
Central Nervous System Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the central nervous system drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the central nervous system drugs market and suggests approaches.
Reasons To Purchase
- Fully updated for 2018.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
Markets Covered: Anaesthetics, Analgesics, Anti-Parkinson drugs, Anti-Epileptics, Other CNS drugs.
Companies Mentioned: Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Pfizer Inc., Novartis AG, Shire Plc., UCB S.A., Eli Lilly And Company, Sanofi S.A., Daiichi Sankyo Company Limited
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
Table of Contents
Central Nervous System Drugs Market Characteristics 5
Central Nervous System Drugs Market Historic Growth (2013-17) 7
Central Nervous System Drugs Market Forecast Growth (2017-21) 8
Central Nervous System Drugs Market Segmentation 10
Global Central Nervous System Drugs Market, Split By Segments, 2017, $ Billion 10
Anti-Parkinson drugs 11
Other CNS drugs 11
Global Central Nervous System Drugs Market, Historic and Forecast, Split By Segments, 2013-2021 12
Central Nervous System Drugs Market Geography Regional and Country Comparison 14
Global Central Nervous System Drugs Market, Split By Regions, 2017 14
Global Central Nervous System Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021 16
Global Central Nervous System Drugs Market, Split By Country, 2017 18
Global Central Nervous System Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021 20
Central Nervous System Drugs Market Competitive Landscape 22
Biogen Inc. 23
F. Hoffmann-La Roche Ltd. 23
Johnson & Johnson 23
Pfizer Inc. 23
Novartis AG 23
Shire Plc. 23
UCB S.A. 23
Eli Lilly And Company 23
Sanofi S.A. 23
Daiichi Sankyo Company, Limited 23
Biogen Idec 24
F.Hoffmann-La Roche 24
Johnson & Johnson (J&J) 25
Central Nervous System Drugs Market Key Mergers And Acquisitions 26
Teva Acquired Auspex Pharmaceuticals 26
Pfizer Acquired Bamboo Therapeutics 26
Sunovion Acquired Cynapsus Therapeutics 26
Novartis Acquired Spinifex Pharmaceuticals 26
Otsuka Acquired Neurovance 26
Biogen Acquired Rodin Therapeutics 27
Central Nervous System Drugs Market Trends And Strategies 28
Wearables To Improve R&D 28
Biomarkers In CNS Drug Development 28
Regenerative Therapies For Central Nervous System Diseases 28
NAICS Definitions Of Industry Covered In This Report 30
Definition Of Market Covered In This Report 30
Research Methodology 31
Research Inquiries 32
The Business Research Company 32
The Business Research Company
47 Anchorage Point,
42 Cuba Street, Canary Wharf,
+44 207 1930 708